Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus after embolization for liver metastases from digestive endocrine tumors
NCT01678664Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Dec 2012
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Neuroendocrine Neoplasm (NEN), liver metastasis, sponsored by Fédération Francophone de Cancérologie Digestive. Started Dec 2012; status: completed.
02
Drugs
everolimus
03
Conditions
Neuroendocrine Neoplasm (NEN)liver metastasis
Beyond the preview
Go deeper on NCT01678664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678664.